Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.373
S.373: Fair Prescription Drug Competition Act
About This Bill
- This bill was introduced in the 112th Congress
- This bill is primarily about congress
- Introduced Feb. 16, 2011
- Latest Major Action Feb. 16, 2011
- See the three similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
5 (All Democrats)
Bill Summary
Fair Prescription Drug Competition Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new drug application has been submitted for approval until the expiration or forfeiture of the 180-day exclusivity period...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Sponsor introductory remarks on measure.
|
|
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
|
Feb. 16, 2011 |
Introduced in the Senate by John D. Rockefeller IV (D-W.Va.) |